Industry
Shanghai Bluesail Boyuan Medical Technology Co., Ltd.
Total Trials
5
Recruiting
2
Active
2
Completed
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
Failure Rate
0.0%
0 terminated/withdrawn out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed trials have results
Key Signals
2 recruiting
Enrollment Performance
Analytics
N/A
4(100.0%)
4Total
N/A(4)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (5)
Showing 5 of 5 trials
NCT07388030Not ApplicableNot Yet Recruiting
Lithotripsy Versus Balloon Angioplasty for Optimal Treatment of CAlcified Lesions With and Without Optical Coherence Tomography evaluatION
Role: lead
NCT06936176Not ApplicableRecruiting
Prospective Trial of IVL for Calcified Carotid Lesions(CREATE Trial)
Role: lead
NCT06936189Recruiting
Prospective Trial of IVL for Calcified Carotid Lesions(CREATE Trial)(Extended Follow-Up)
Role: lead
NCT06924736Not ApplicableNot Yet Recruiting
SONICURE(SONICracker for the Treatment of UndeRExpansion)
Role: lead
NCT05649488Not ApplicableUnknown
Evaluate the Safety and Efficacy of Intracoronary Lithotripsy Balloon Catheter and Intracoronary Lithotripsy Apparatus
Role: lead
All 5 trials loaded